carlisle medical
Refill Requests shipment tracking contact carlisle medical
Knowledge Center
generic drug updates
Launch of Generic Naprelan CR Tablets
Released: 03/11/2015
By: Carl Richie, Pharmacy Manager

The generic equivalent of Naprelan CR tablets (naproxen sodium controlled release) has just been launched, following approval by the FDA (Food and Drug Administration.) Naprelan is a member of the nonsteroidal anti-inflammatory drugs (NSAIDs) group. It is designed to relieve pain and reduce joint stiffness and swelling.

Generic prescription drugs approved by the FDA have the same high quality and strength as brand name drugs. Generic prescription drug manufacturing and packaging sites must pass the same quality standards as those of brand name drugs.

Over the next 30 days, Carlisle Medical will be contacting physicians to inform them that the generic version of Naprelan CR is available.

If you have any questions or if we may assist you with your pharmacy needs, please contact us at 800-553-1783 or at pharmacy@carlislemedical.com

<<Back
 
Company News
Generic Releases
Industry Related News
Industry Related Links
Newsletter Subscription
Newsletter Login
 
 
 
 
 
© Copyright 2018 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer